These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9173223

  • 21. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA, Gimson AE, Gibbs P, Alexander GJ.
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [Abstract] [Full Text] [Related]

  • 22. Non-surgical periodontal therapy of cyclosporin A gingival overgrowth in organ transplant patients. Clinical results at 12 months.
    Aimetti M, Romano F, Priotto P, Debernardi C.
    Minerva Stomatol; 2005 May; 54(5):311-9. PubMed ID: 15985985
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S, Hashikura Y, Katsuyama Y, Ikegami T, Nakazawa Y, Urata K, Terada M, Miyagawa S, Kawasaki S.
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Controversies about the use of calcineurin inhibitors in pediatric patients].
    Dello Strologo L.
    G Ital Nefrol; 2008 Mar; 25(3):317-24. PubMed ID: 18473303
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Non-lymphoid cancer after liver transplantation.
    Frezza EE, Fung JJ, van Thiel DH.
    Hepatogastroenterology; 1997 Mar; 44(16):1172-81. PubMed ID: 9261620
    [Abstract] [Full Text] [Related]

  • 34. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ, Hilbrands LB.
    Clin Transplant; 2006 Mar; 20(5):659-64. PubMed ID: 16968494
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R, Bussenius-Kammerer M, Reck T, Koch CA, Kissler H, Hohenberger W, Müller V.
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
    Margreiter R, Pohanka E, Sparacino V, Sperschneider H, Kunzendorf U, Huber W, Lameire N, Andreucci VE, Donati D, Heemann U, European Switch to Tacrolimus Study Group.
    Transpl Int; 2005 Jul; 18(7):816-23. PubMed ID: 15948861
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of Cyclosporin A on gingival status following liver transplantation.
    Ross PJ, Nazif MM, Zullo T, Zitelli B, Guevara P.
    ASDC J Dent Child; 1989 Jul; 56(1):56-9. PubMed ID: 2643647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.